登录

EDDA Technology Secures $150 Million in New Financing Round

作者: Mailman 2021-04-22 15:21
EDDA Healthcare and Technology Holding
https://www.eddatech.com.cn/
企业数据由 动脉橙 提供支持
智能手术机器人研发商、精准外科智能全方案提供商 | 战略融资 | 运营中
美国-新泽西州
2021-04-07
融资金额:$1.5亿
SoftBank Vision Fund
查看

(VCBeat) Apr. 07, 2021 -- EDDA Healthcare and Technology Holding Ltd., an innovator of intelligent surgical robotics and overall precision surgery solution, and its subsidiaries, EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc (Princeton, NJ, USA), (hereafter jointly referred to as "EDDA Technology"),  today announced the closing of a $150 million financing round. The latest round was led by Softbank Vision Fund 2,  with participation from OrbiMed and 3W Fund. Prior investors include Morningside Ventures, Matrix Partners China, SBCVC, BOCGI, Trust Bridge, and Draper Dragon, etc.


EDDA Technology is an innovative leader in the rapidly growing field of medical imaging-assisted precision surgery for cancers. It takes the lead in the domestic and international markets. EEDDA Technology's platform with independent intellectual property rights can provide a series of products and services. With surgical robots as the core, EEDDA Technology provides doctors with overall precision surgery solutions. Its products have been applied in Mayo Clinic, Peking Union Medical College Hospital, Sichuan West China Hospital, Shanghai Ruijin Hospital, and hundreds of other hospitals worldwide.


In creating an IQQA® platform, EDDA Technology brings Precision 3D medical innovative imaging solutions to support physicians and enable improved workflow and patient care in open/minimally invasive/robotic surgery. The end-to-end enabling platform for surgery provides support for pre-surgical planning and simulation, intra-operative guidance and monitoring, post-operative follow-up evaluation, training.


In 2020, China NMPA granted Category III registration certificate for EEDDA Technology's IQQA®-Guide as the country's first surgical navigation medical device for soft tissue organs, with a statement describing it as having "significant clinical benefits, increasing interventional accuracy, reducing the number of needle passes and intraoperative CT scanning". The product was also cleared by the US FDA.


The funding will be used for the development of EEDDA Technology's products under R&D, market promotion and commercialization of existing product lines, and promotion of the strategic cooperation planning, so as to build a precision surgery technology platform with intelligent cloud service + surgical robot as the core, enabling doctors to better serve patients.


>>>>

About Softbank Vision Fund


SoftBank Vision Fund is a subsidiary of Softbank Group that specializes in growth capital and social impact investments. Sectors that the fund invests in include internet-of-things, artificial intelligence (AI), robotics, communications infrastructure, telecoms, computational biology, biotech, cloud technologies and software, consumer internet businesses, financial technology, and mobile apps. 


>>>>

About OrbiMed


OrbiMed is a healthcare-dedicated investment firm, with approximately US$5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies.

相关赛道 医疗机器人
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

完成近亿美元D轮融资,平安资本领投的润迈德医疗如何让“无人手术室”概念落地?

Meio CadiNav Medical Completes Pre-Series A Financing

辰德资本合伙人谈庆:狙击医疗器械创新,技术变革带动市场新机遇【投资人说】

Yi Chao Medical Announces ¥10M Series A Financing

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Hyperway Secures ¥10 Million in Series A Funding

2021-04-22
下一篇

TechnoDerma Brings in ¥10 million in a Series A Round

2021-04-22